Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Title
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
Authors
Keywords
-
Journal
GYNECOLOGIC ONCOLOGY
Volume 116, Issue 1, Pages 15-20
Publisher
Elsevier BV
Online
2009-10-19
DOI
10.1016/j.ygyno.2009.09.025

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation